Cns Pharmaceuticals Inc (CNSP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 10-1985 | 10-1984 | |
| Cash Flows From Operating Activities | ||
| Net Income | 1,866 | 640 |
| Depreciation Amortization | 745 | 301 |
| Other Working Capital | 176 | 50 |
| Other Operating Activity | 0 | 9 |
| Operating Cash Flow | $2,787 | $1,000 |
| Cash Flows From Investing Activities | ||
| Other Investing Activity | 19,150 | 15,500 |
| Investing Cash Flow | $19,150 | $15,500 |
| Cash Flows From Financing Activities | ||
| Other Financing Activity | 2,000 | 17,115 |
| Financing Cash Flow | $2,000 | $17,115 |
| Exchange Rate Effect | N/A | 8,219 |
| Beginning Cash Position | 16,785 | 9,188 |
| End Cash Position | 11,771 | 7,313 |
| Net Cash Flow | $1,413 | $92 |
| Free Cash Flow | ||
| Operating Cash Flow | 2,787 | 1,000 |
| Free Cash Flow | 2,787 | 1,000 |